Ch 39Lower Respiratory Disorders: Comprehensive Study Notes
Lower Respiratory System Fundamentals
Lung Compliance
Refers to lung volume based on the pressure within the alveoli.
Factors influencing compliance:
Connective tissue.
Surface tension in the alveoli.
Control of Respiration
Influenced by the concentrations of oxygen (), carbon dioxide (), and hydrogen () ions in the blood.
Bronchial Smooth Muscle
Plays a significant role in airway diameter and resistance.
Lower Respiratory Disorders
Asthma
An inflammatory disorder affecting the airway walls.
Characterized by airway obstruction.
Triggers:
Stress.
Allergens.
Pollutants.
Signs/Symptoms:
Bronchospasm.
Dyspnea (shortness of breath).
Excessive mucus secretions.
Wheezing.
Coughing.
Tightness in the chest.
Bronchial Asthma: Pathophysiological Changes
Allergens attach to mast cells and basophils, initiating an antigen-antibody reaction on the mast cells.
Mast cells are stimulated to release chemical mediators (e.g., histamine, leukotrienes).
An inflammatory process ensues.
This leads to increased resistance to airflow due to airway obstruction.
Signs/Symptoms (reiterated):
Bronchospasm.
Wheezing.
Dyspnea.
Mucus secretions.
Chronic Bronchitis
Pathophysiological Changes:
Bronchial inflammation.
Excessive mucus secretions, leading to airway obstruction.
Causes:
Smoking.
Chronic lung infections.
Signs/Symptoms:
Productive cough.
Hypoxemia (low blood oxygen).
Rhonchi (coarse rattling sounds in the lungs).
Hypercapnia (high blood carbon dioxide).
Respiratory acidosis.
Bronchiectasis
Pathophysiological Changes:
Abnormal and irreversible dilation of the bronchi and bronchioles.
Bronchioles become obstructed due to the breakdown of the epithelium of the bronchial mucosa.
Tissue fibrosis may eventually occur.
Causes:
Frequent infections.
Persistent inflammation.
Emphysema
A progressive lung disease.
Pathophysiological Changes:
Proteolytic enzymes are released in the lung by bacteria or phagocytic cells.
Terminal bronchioles become plugged with mucus.
This leads to a loss in the fiber and elastin network within the alveoli.
Alveolar walls are destroyed.
Air becomes trapped in enlarged, overexpanded alveoli, resulting in inadequate gas exchange.
Causes:
Cigarette smoking.
Atmospheric contaminants.
Lack of the alpha1-antitrypsin protein.
Chronic Obstructive Pulmonary Disease (COPD)
Pathophysiological Changes:
Characterized by airway obstruction with increased airway resistance to airflow to lung tissues.
Major Causes:
Chronic bronchitis.
Bronchiectasis.
Emphysema.
Asthma (often considered a component or comorbidity that contributes to COPD features).
Restrictive Lung Disease
Pathophysiological Changes:
Involves a decrease in total lung capacity.
This is due to fluid accumulation and/or loss of elasticity of lung tissues.
Etiology (Causes):
Pulmonary edema.
Pulmonary fibrosis.
Pneumonitis.
Lung tumors.
Thoracic deformities (e.g., scoliosis).
Thoracic muscular disorders (e.g., myasthenia gravis).
Pharmacological Management of Lower Respiratory Disorders
Bronchodilators: Sympathomimetics
Epinephrine
Action: Increases cyclic adenosine monophosphate (cAMP) in lung tissue, leading to bronchodilation. It also restores circulation and increases airway patency.
Use: Acute bronchospasm, asthma, anaphylaxis, angioedema, nasal congestion, status asthmaticus.
Side Effects: Dizziness, tremors, hypertension, angina, palpitations, tachycardia, dysrhythmias, restlessness.
Bronchodilators: Selective Beta-Adrenergics
Albuterol
Action: Directly causes bronchodilation.
Properties: Rapid onset of action, longer duration of action compared to non-selective beta-agonists, generally few side effects.
Use: Asthma, acute bronchospasm, bronchospasm prophylaxis.
Common Side Effects: Headache, rhinitis, excitability, tremors, paradoxical bronchospasm, palpitations, tachycardia.
Metaproterenol
Administration: Inhalation is the preferred route for long-term asthma treatment.
Use: Acute bronchospasm, asthma, COPD.
Common Side Effects: Headache, dizziness, tremor, nausea, palpitations, tachycardia, angina.
Anticholinergics
Tiotropium
Use: Maintenance treatment of bronchospasms associated with COPD.
Administration: Administered by inhalation only using the HandiHaler device (a dry-powder capsule inhaler).
Common Side Effects: Dry mouth, constipation, GI distress, depression, insomnia, headache, pharyngitis, sinusitis, infection, arthralgia, peripheral edema.
Methylxanthine Derivatives
Theophylline
Action: Relaxes smooth muscle of the bronchi and bronchioles by increasing cAMP, thereby promoting bronchodilation.
Use: Asthma.
Therapeutic Range: mcg/mL. Toxicity is generally observed when levels are greater than mcg/mL.
Side Effects/Adverse Effects: Dizziness, headache, irritability, restlessness, hypokalemia, GI distress, seizure, insomnia, tachycardia, palpitations, hypotension, dysrhythmias.
Leukotriene Receptor Antagonists (LTRAs)
Action: Reduce the inflammatory process and decrease bronchoconstriction.
Use: Asthma prophylaxis, prophylaxis of exercise-induced bronchospasm.
Important Note: Not recommended for acute asthmatic attacks.
Common Side Effects: Dizziness, headache, confusion, GI distress, depression, weakness, infection.
Glucocorticoids (Steroids)
Action: Primarily exert an antiinflammatory effect.
Administration: Can be given via MDI inhaler, orally as a tablet, or intravenously.
Side Effects: Dry mouth, throat irritation, hoarseness, cough, headache, euphoria, confusion, depression, hyperglycemia, GI distress, hypertension, insomnia, weakness, fluid retention, diaphoresis, osteoporosis, psychosis, superinfections (e.g., oral candidiasis), menstrual irregularities, electrolyte imbalance.
Cromolyn
Action: Inhibits histamine release, effectively preventing asthmatic attacks.
Use: Prophylaxis of bronchial asthma.
Common Side Effects: Cough, postnasal drip.
Adverse Effect: Rebound bronchospasm.
Drug Therapy for Asthma According to Severity
Chronic Asthma: Managed with a long-term medication program. A quick-relief program is also used for the acute phase. The specific long-term program can vary based on asthma symptoms and severity.
Drug Therapy for Asthma According to Age
Young Children: Cromolyn is used to treat the inflammatory effects of asthma. Oral glucocorticoids may be prescribed to control moderate to severe asthmatic states.
Older Adults: Requires careful consideration of drug selection and dosage due to potential adverse effects and comorbidities.
Clinical Judgment in Medication Administration
Bronchodilator Administration
Concept: Oxygenation.
Recognize Cues: Assess for wheezing, decreased breath sounds, cough, sputum production, and patient's hydration status.
Analyze Cues and Prioritize Hypothesis: Address dyspnea and decreased gas exchange.
Generate Solutions: Aim for the patient's wheezing to be eliminated or significantly diminished; expect lung fields to clear within to days.
Take Action:
Monitor vital signs regularly.
Ensure adequate hydration (oral or intravenous).
Observe for and document any side effects.
Administer medication at regular intervals around the clock to maintain a sustained therapeutic level.
Advise patients experiencing asthmatic attacks to wear an identification bracelet or MedicAlert tag.
Evaluate Outcomes: Regularly assess the effectiveness of the intervention against the generated solutions.
Leukotriene Receptor Antagonist Administration
Concept: Oxygenation.
Recognize Cues: Assess for wheezing, decreased breath sounds, cough, sputum production, and patient's hydration status.
Analyze Cues and Prioritize Hypothesis: Address dyspnea and airway obstruction.
Generate Solutions: Aim for the patient's lung fields to be clear within to days.
Take Action:
Monitor respirations for rate, depth, rhythm, and type.
Monitor lung sounds for rhonchi, wheezing, or rales.
Observe lips and fingernails for cyanosis.
Monitor liver function tests periodically, as some LTRAs can affect liver function.
Encourage the patient to stop smoking.
Advise patients who experience frequent or severe asthmatic attacks to wear an identification bracelet or MedicAlert tag.
Evaluate Outcomes: Continually assess patient response and adjust care as needed.
Practice Questions and Key Learnings
Metaproterenol Side Effects: Tremors are a common side effect of metaproterenol and other beta-adrenergic agonists.
Albuterol Action: Albuterol dilates the bronchioles, providing relief from bronchospasm. (The phrasing